Deal Watch: Pfizer To Collaborate On Chimeric Cancer Immunotherapies With France’s Cellectis
Executive Summary
Janssen licenses influenza A candidate from Vertex, while Cepheid is teaming with three biopharma firms on a diagnostic for multi-drug-resistant bacterial infections.